Chengdu Easton Bio Pharmaceuticals Co., Ltd. logo

Chengdu Easton Bio Pharmaceuticals Co., Ltd. (688513)

Market Closed
16 Oct, 06:57 AM
SSE SSE
¥
45. 39
-0.61
-1.3261%
¥
5.48B Market Cap
- P/E Ratio
2.32% Div Yield
2.01M Volume
- Eps
¥ 46
Previous Close
Add Transaction
Day Range
45.18 48.45
Year Range
40.25 80.48
Want to track 688513 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Chengdu Easton Bio Pharmaceuticals Co., Ltd. (688513) Statistics

Valuation metrics

Market Cap 5.48B
Enterprise value 8.02B
Trailing P/E (ttm) 28.87
Forward P/E -
PEG ratio 1.25
Price/Sales (ttm) 6.1
Price/Book (mrq) 2.75
Enterprise Value/Revenue 6
Enterprise Value/EBITDA 25.4

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.43M
Average volume (90 days) 2.73M

Price summary

52-Week low 40.25
52-Week high 80.48
Beta -
50-Day moving average 46.73
200-Day moving average 53.33

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.49
Trailing annual dividend yield 0.0106%
5-Year annual dividend yield -
Payout ratio 0.31
Dividend Date 2 Jun 2026
Ex-Dividend Date 2 Jun 2026
Last split factor 1:1
Last split Date 1 Jul 2024

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.21%
Operating margin 0.19%

Operational effectiveness

Return on assets 0.07%
Return on equity 0.09%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 7.66
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.59
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 9.59
Total debt (mrq) -
Total Debt/Equity (mrq) 0.07
Current ratio (mrq) 3.25%
Book value per share (mrq) 17.33

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -